Rongrong Zhou

16PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersCentral nervous systemCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 06, 2026
Radiogenomic modeling of EGFR mutation status in brain metastases from lung adenocarcinoma: a multicenter study with biological interpretability.

|Jan 22, 2025
Predicting Survival Rates in Brain Metastases Patients from Non-Small Cell Lung Cancer Using Radiomic Signatures Associated with Tumor Immune Heterogeneity.

Fuxing Deng, Gang Xiao, Guilong Tanzhu

|Nov 27, 2024
An immune scoring system predicts prognosis and immune characteristics in lung adenocarcinoma brain metastases by RNA sequencing.

Gang Xiao, Guilong Tanzhu, Xuan Gao

|Nov 05, 2024
The Optimal Radiotherapy Strategy for Patients With Small Cell Lung Cancer and Brain Metastasis: A Retrospective Analysis.

Qian Zeng, Xianjing Chu, Gang Xiao

|Aug 29, 2024
Cost-effectiveness analysis of osimertinib plus chemotherapy for patients with EGFR-mutated advanced non-small cell lung cancer.

Wentao Tian, Lishui Niu, Rongrong Zhou

|Jun 17, 2024
Efficacy and safety of personalized optimal PD-(L)1 combinations in advanced NSCLC: a network meta-analysis.

Xianjing Chu, Wentao Tian, Jiaoyang Ning

Pageof 3

Frequent Collaborators

3 joint publications

Wentao Tian

2 joint publications

Pansong Li

2 joint publications

Gang Xiao

2 joint publications

Zijian Zhang